Pfizer is one of the world's largest pharmaceutical companies. It has a few material patent expirations on the horizon. It's doing what it has to do to deal with that headwind and others. Pfizer is ...
Pfizer's oncology portfolio has produced a second positive phase 3 trial in HER2-positive breast cancer in the span of about a year. This time, the drug that delivered the positive readout is Tukysa, ...
For the second year running, Pfizer has arrived at the European Society for Medical Oncology (ESMO) conference armed with data showing its one-time heart failure hopeful ponsegromab can treat a ...
The U.S. pharmaceutical industry needs to collaborate with China, given the country's relatively faster drug development, Pfizer (NYSE:PFE) CEO Albert Bourla said at an event on Tuesday. "In biopharma ...
Pfizer evelops and markets branded medicines, vaccines, and biosimilars across therapeutic areas such as cardiovascular, oncology, infectious diseases, and immunology. The company generates revenue ...
Women who use Depo-Provera face a higher risk of developing a slow-growing brain tumor, according to a new study that comes as the contraceptive’s maker, Pfizer, faces hundreds of lawsuits claiming ...
This trial tested a new treatment for patients with a type of breast cancer (metastatic breast cancer (MBC)) that is positive for HER2, which means the cancer cells have a specific protein that helps ...
Pfizer stock (NYSE: PFE) is currently in a significant slump, marking its ninth consecutive day of decline and losing a total of −11% of its value over that period. This sustained sell-off has wiped ...
Oct 18 (Reuters) - Pfizer (PFE.N), opens new tab and Japanese firm Astellas' (4503.T), opens new tab drug Padcev, combined with Merck's (MRK.N), opens new tab Keytruda, lowered the risk of tumor ...
Pfizer Chief Executive Officer Albert Bourla said that vaccines are harder to get approved right now as Health Secretary Robert F. Kennedy Jr. looks to overhaul the country’s immunization policies.
Acumen Capital Partners has landed a $125 million loan to refinance an industrial asset in Brooklyn that was formerly Pfizer’s headquarters. “630 Flushing stands as a premier industrial and ...
NEW YORK, Oct 14 (Reuters) - Pfizer Chief Executive Albert Bourla said on Tuesday that the U.S. pharmaceutical industry needs to collaborate with China’s, where speedy processes have vaulted it to 30% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback